out of 171,460 shares HB sold 59,220 shares on market and kept only 112,240.

"So was the 13G/a filing actually a payoff to HB to dismiss? "

Nope!

It came from their last remaining warrants as per following deal on Dec 28th 2018

http://phx.corporate-ir.net/phoenix.zhtml?c=123840&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTEyNjE2MjQ0JkRTRVE9MCZTRVE9MCZTUURFU0M9U0VDVElPTl9FTlRJUkUmc3Vic2lkPTU3



HB is completely out of DCTH except these last stocks!

hang in there! it's cominggggggggggggg

Yes you're right, I hate those DGF's 0.01$ warrant deal.
Very high probability of it getting cancelled as per terms company can cancel it anytime and buy it back.
But on the same new money deal will be needed to run the company from April-May onwards, hope they do better deal, hopefully above 1.75$ to keep their promise and we get our return!
Accumulation has started since last Friday, let's see how it goes!

GO MEDAC GO!

first marketing article seen from Medac side mentioning Chemosat

It's REAL!

https://www.abendblatt.de/region/pinneberg/article216307803/Von-Wedel-aus-erobert-Medac-die-Welt.html

"One of these drugs is the medical device Chemosat, which was established on the European market earlier this year. It is aimed at a smaller group of people. According to company spokesman, 400 people are affected by the disease nationwide, but otherwise there is no cure for it. It is about patients with liver cancer whose metastases have spread so much that they can not be surgically removed. Chemotherapy can only help if it is very strong and that would destroy healthy organs. The idea behind the Medac product: A filter is used to isolate the liver from the body's bloodstream and inject the anticancer drug directly into the liver in concentrated doses."

"We are confident that we will be able to offer four to five new drugs and medical devices by the summer," says Medac Managing Director Jörg Hans.
Photo: Michael Zapf / medac

wrong info and wrong advise if that group held the stocks on May 4th 2018.
they could have made 400% on after RS bounce due to no warrants or stocks were available to sell, that was not the typical RS.
There's where people goes wrong.

In your Journey another wrong move was selling your thousands of stocks before subs at 2.5$ ish which you published to buy subs at 1.75$ with same money.

If you didn't do that you would have made or recovered lot of money.

With all due respect please tell your exact story and your buying and selling decisions when you paint the scary picture based on your wrong investment judgement.

We closed at 1.35$ on 05/03/2018 and faster forward 8 months we are about 1$ less than we were 8 months ago.
and that sounds about right for an almost bankrupt company who is trying for recovery.

As long a they keep making "right decisions" it's going to be huge victory!

only bad decision Delcath made in 2018 was offering those stupid 0.01$ warrants and they are hurting the stock so far!

sounds fair, let's keep it that way!

you keep your losses we will keep our excitement how's that?
Please keep the negativity out of here without any proof!

hold your excitement for couple more weeks.

As per PR they will start this month

"medac is currently working diligently with Delcath launching commercial efforts in Europe in January 2019."

Try to add Europe treatments being counted in this trial in your calculation and you will reach to around June 2019 I think.

To the point they were supposed to be out of money by last December before Medac deal came out!
How are they surviving without printing any new stocks or dilutive deals?
MEDAC deal is real to whoever wanted an answer, they got 7 million $ cash IMO.
NO deal has came out since September under 1.75$ - preferred stocks.
I expect no need of money or need to printing any new deals till May and looking forward to surprising NDA filing in these upcoming months to get a nice return as a long!

Thanks for confirming.

Are we bankrupt yet?

so you are saying you were making money on bought shares while you were shouting bankruptcy is coming bankruptcy is comingggggggggg.
Oh I see just like right now?

Thank you for caring so much, My break even is wayyyyyyy far, I really hope I break even, currently holding 21549 at 0.3512$.
even a 1000% storm won't be able to help me break even!

I remember dcth going up 400% on May 4th 2018 the day after last RS, this is always volatile and un predictable.
But I will agree on waste of time thought.

LOL then you short more and I buy more

The unusual silence from them says, it's the calm before the "storm 2.0"!

when they asked for last RS vote in Feb 2018 this is what they gave as reason. I think Nasdaq launch back in their priority but how will they do it that's the big unknown.

following from DEF 14A from Feb 2018

In determining which reverse stock split ratio to implement, if any, following receipt of stockholder approval, the Board of Directors may consider,
among other things, various factors, such as:
• the historical trading price and trading volume of our Common Stock;
• the then-prevailing trading price and trading volume of our Common Stock and the expected impact of the reverse stock split on the trading
market for our Common Stock in the short- and long-term;
• our ability to possibly regain our listing on The NASDAQ Capital Market;
• which reverse stock split ratio would result in the least administrative cost to us; and
• prevailing general market and economic conditions.

That guessing was based on yearly revenue being generated from Europe, we know that's directly coming from Chemosat program. 3 million yearly revenue / X $ for treatment = X numbers of treatments per year plus some guessing of x numbers of average treatment per patient!
total unknown is US patients, that's impossible to guess!
Company has repeated end of trial 3 times by June 2019, so it makes sense I think.
As per FDA website they are enrolling at 31 locations world wide.
how much longer it take to find/treat 3 patients per site? again guess.

good job DE for bringing up the Section 9(d) the Backstop Agreements.
you were right!

My guess is they must be at 50-60% enrollment of total 80 patients since Europe data is being counted in this single ARM trial, it's way faster than only domestic trials.
I firmly believe June 2019 or early finish is possible!

Comeback Time for Delcath Systems, Inc

https://microcapdaily.com/comeback-time-for-delcath-systems-inc-otcmkts-dcth/122941/


Enjoyyyyyyyyyyy

If you paid attention to the dilution table list they came up with before ER, the only party who was diluting before year end was HB/Alto listed as November 2017/ February 2018 holders, they are the one who had those last 1 million plus warrants, they are gone so is the dilution for now.
all other 0.01$ warrants are held with DGF and they are not seems to be executing anything from long time.
I predict shares shortage scenario if DGF never sells anything till we go way higher than 1.75$.
thoughts?

In my mind company is finally completely out of HB mess and their stock damaging tactics.

Game is back in to DGF's hands now.

DGF= Discover growth fund

L
o
L

Lol yeah seems like Medac is saying lot of things to different people!

Lol, I contacted Medeac they said everything is right!

as per PR

"Heiner Will, Chief Marketing Officer of medac, said, “We are excited to build upon the growing customer and revenue base that Delcath has built in Europe to provide patients with liver metastases a promising treatment modality. We are convinced by the assessment of European clinicians about the very meaningful impact CHEMOSAT has on the quality of life of these patients who, because of the safety profile of CHEMOSAT can receive multiple treatments.” This substantial new business opportunity strengthens and expands medac’s expertise in the treatment of cancer. medac is currently working diligently with Delcath launching commercial efforts in Europe in January 2019."


https://www.linkedin.com/in/heiner-will-b90979a3/?originalSubdomain=de

this line from PR "medac will pay Delcath €6,000,000 in a combination of upfront and success-based milestone payments." so we'll see what's what when they say it, while we wait if a new money deal comes out consider Medac deal was not enough and may trigger my exit!

Yes a year ago they said due to money constraints they were slow enrolling.
lately I haven not seen that warning anywhere, they are repeating June 2019 enrollment finish again and again.
If this medac deal is for real money wise they should be good till May-June with 7 million $ cash and hopefully more royalty every month but the deal details should come out from company I hope or we'll find out by next ER or if they sell/print more stocks to raise money we'll know medac deal failed!
that is how i'm going to continue my investment, I will not take any convertible deal with less than 1.75$ face value if they do i'm out!
Currently holding 21549 stocks.

Good speculative scenario but I would speculate them pushing chemosat in other countries where approval is not needed, direct marketing can bring revenue over night.
US revenue will take some time unless they finish trial faster than anticipated that's the truth.

Thanks for appreciation, Hope we all longs make or recovery investment money this time!
Hang in there with Caution!

you would think they want to sell the company for 3 million $?
They are fishing for big money in 2-3 years after FDA approval.
The market potential is in billions of $!
Even if someone tries they won't allow anyone to takeover forcefully!

welcome back!

They are desperate for survival from a long time and have been doing everything to survive at the cost of investors and share holders.
Hope the situation has changed now with proper cash flow and better negotiation techniques.

I can't predict the exact stock price, beyond my control but company's market cap is too small for the position they are in, way better than last couple years.
That's why i'm a buyer, expecting substantial return, again can't predict how soon.
yeah there are some risks and they can't be ignored too but it's worth taking risk at these prices.
I think low was 0.23$ ish.

don't know the names but I said strong buy at 1.75$ million times before it went up again and again and again!
I said strong buy from market not the subscription strong buy!
OS was tiny and it was obvious what would happen.
Just like now, it's obvious what's going to happen next!

That is what exactly my point is, if you buy at the wrong time you can never come out of it.
I never bought the subscriptions but it was unknown and no one knew how much will be raised.
and I was a seller at high prices because it was too much for the situation at that time.
There were so many opportunities to make money so no complaints please.
And more will come but you will fool your self if you buy it at wrong time that's a given.

Yeah Medac is the big deal for sure
they are moving in right direction!
As per PR they cover Europe and 3-4 more countries arond.
all member states of the European Union, Norway, Liechtenstein, Switzerland, and the United Kingdom.
Good luck for dip buying!

that sounds like a normal behavior for Dcth! Lol

looking very much forward to it!

Fully loaded!